| Literature DB >> 35483134 |
Tobias Mantel1, Angela Jochim1, Tobias Meindl1, Jonas Deppe1, Claus Zimmer2, Yong Li1, Bernhard Haslinger3.
Abstract
BACKGROUND: Blepharospasm is a debilitating focal dystonia characterized by involuntary eyelid spasms that can be accompanied by oromandibular muscle involvement (Meige's syndrome). Frequently observed abnormality in functional neuroimaging hints at an important position of the thalamus, that relays involved cortico-basal ganglia-cortical and cortico-cerebello-cortical circuits, within the abnormal network in blepharospasm.Entities:
Keywords: Blepharospasm; Diffusion tractography; Focal dystonia; Thalamus connectivity mapping
Mesh:
Year: 2022 PMID: 35483134 PMCID: PMC9125780 DOI: 10.1016/j.nicl.2022.103013
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.891
Demographic and clinical characteristics.
| Dystonia patients (n = 17) | Healthy controls (n = 17) | p-value | |
|---|---|---|---|
| Age, years (mean, SD) | 62.2, 10.7 | 62.4, 10.2 | 0.951) |
| Sex (male/female) | 10/7 | 10/7 | 1.02) |
| TIV, cm3 (mean, SD) | 1421.2, 105.5 | 1478.9, 110.3 | 0.131) |
| Disease duration, years (mean, SD) | 9.24, 6.51 | – | |
| Light sensitivity (yes/no) | 14/3 | ||
| Treatment duration, years (mean, SD) | 6.74, 6.72 | – | |
| Interval since last treatment, weeks (mean, SD) | 12.4, 1.79 | – | |
| Treatment doses, MU (mean, SD) | |||
| -Onoabotulinumtoxin (Botox®, 7 patients) | 43.00, 13.88 | – | |
| -Incoboutlinumtoxin (Xeomin®, 3 patients) | 66.5, 9.97 | ||
| -Abobotulinumtoxin (Dysport®, 7 patients) | 162.86, 31.94 | ||
| Blepharospasm Disability Scale (median, IQR / mean, SD)b | 0.48, 0.24 / 0.51, 0.23 | – | |
| Jankovic Rating Scale | 5, 3 / 4.35, 2.74 | – | |
Demographic and clinical characteristics of orofacial dystonia patients and healthy controls. Statistical between-group comparisons of demographic characteristics were conducted using 1)t-tests and 2)Wilcoxon-Mann-Whitney tests. SD = standard deviation; IQR = interquartile range; MU, mouse units; y = years; h = hours; TIV = total intracranial volume; m = male; f = female.
Fig. 1Results of the thalamic SC mapping analysis in blepharospasm/Meige’s syndrome patients and healthy controls, displayed in neurological convention in standard (MNI) space. Section A: Individual group results of the thalamic connectivity mapping for each of the six investigated cortical regions of interest in each hemisphere. Colorbar indicates percent overlay of trajectories across participants in each group at an average connection probability threshold of 10%. Section B: Significant local SC group differences found for the motor/premotor and occipital SC distributions (pFWE(TFCE) < 0.0083 (0.05/6). Section C: the corresponding results of the topographic analysis calculated from the unthresholded thalamic SC distribution’s centers of gravity (CoGs) as surrogate marker. Asterisks highlight significant differences. PAT, dystonia patients; CON, healthy controls; L, left hemisphere, R, right hemisphere.
Fig. 2Results of post-hoc reconstruction and group comparison of the probable trajectories of the dentato-thalamo-cortical tract (DTCT) and the pallido-thalamo-cortical tract (PTCT) targeting the left occipital and the right motor/premotor cortex respectively. Upper panel: Overview over subcortical sections of reconstructed projections (for more extensive depiction, see supplemental figure s-3). For visualization purpose, images were thresholded to show voxels shared among at least 4/34 participants at a connection probability threshold of 5%. Lower panel: Results of the group comparison of average FA in representative tract segments, visualized as box plots (maximum whisker length = 1.5*IQR), with grey diamonds indicating single values. Asterisks marks significant (p < 0.05) group differences in the nonparametric statistical analysis. PAT, dystonia patients; CON, healthy controls; FA, fractional anisotropy; L(H), left hemisphere; R(H), right hemisphere.